Preparation Instructions
This enzyme is soluble in 20 mM sodium phosphate
buffer (pH 7.0), with 77 mM sodium chloride and
0.1 mg/mL BSA at 1 mg/mL, yielding a clear solution.
Storage/Stability
treatment. J. Immunol. Methods,
175(1), 69-77 (1994).
7. Pederson, E. D., et al., Reducing medium for the
cultivation of Porphyromonas gingivalis.
Microbios., 89(359), 119-124 (1997).
8. Wang, L.
USA, 89(17), 8356-
8360 (1992).
3. de Witte, L. et al., Syndecan-3 is a dendritic cell-
specific attachment receptor for HIV-1. Proc. Natl.
Acad. Sci. USA. 104(49), 19464-19469 (2007).
4. Raja
but not by glycosylation inhibitor,
tunicamycin, in human prostate cancer cells., J.
Cell Biochem., 77, 396-408 (2000).
9. Aagaard-Tillery, K.M. and Jelinek, D.F., Differential
activation of a calcium-dependent
binding
properties of the iron-containing protein of
Escherichia coli B. J. Biol. Chem., 251, 5472-77
(1976).
14. Beyer, W., et al., Superoxide dismutases. Prog.
Nucleic Acid Res. Mol. Biol., 40
binding
properties of the iron-containing protein of
Escherichia coli B. J. Biol. Chem., 251, 5472-77
(1976).
14. Beyer, W., et al., Superoxide dismutases. Prog.
Nucleic Acid Res. Mol. Biol., 40
high-performance
liquid chromatography with fluorescence detection.
J. Chromatogr. A, 882(1-2), 63-77 (2000).
12. Delepee, R., and Pouliquen, H., Determination of
oxolinic acid in the bryophyte Fontinalis
but not by glycosylation inhibitor,
tunicamycin, in human prostate cancer cells. J. Cell
Biochem., 77, 396-408 (2000).
8. Aagaard-Tillery, K.M., and Jelinek, D.F., Differential
activation of a calcium-dependent
but not by glycosylation inhibitor,
tunicamycin, in human prostate cancer cells. J. Cell
Biochem., 77, 396-408 (2000).
10. Aagaard-Tillery, K.M., and Jelinek, D.F., Differential
activation of a calcium-dependent